The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
New research reveals potential breakthrough for West Australians living with chronic fatigue
Angela Pownall
The West Australian
Sat, 24 January 2026
Scientists say they have new proof that a particular cellular dysfunction could be the key to helping up to 250,000 Australians who suffer from chronic fatigue.
New research, partly carried out in Perth, showed that people diagnosed with myalgic encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS) had a genetic fault that influenced how calcium was absorbed into their immune cells.
Medscape Medical News > Conference News > IACFS/ME 2025
Research Into ME/CFS Pathology Points to Possible Treatments
Miriam E. Tucker
November 07, 2025
New possibilities for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are emerging as research continues to untangle the complex, multisystem pathophysiology of the two overlapping diseases.
Research Into ME/CFS Pathology Points to Possible Treatments
Miriam E. Tucker
November 07, 2025
New possibilities for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are emerging as research continues to untangle the complex, multisystem pathophysiology of the two overlapping diseases.
Journal of Translational Medicine
2024 Jul 5;22(1):630.
Matthias Löhn & Klaus Josef Wirth
Review Open access Published: 05 July 2024
Volume 22, article number 630, (2024)
Matthias Löhn & Klaus Josef Wirth
Potential pathophysiological role of the ion channel TRPM3 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the therapeutic effect of low-dose naltrexone
05 July 2024, Volume 22, article number 630, (2024)
Matthias Löhn and Klaus Josef Wirth
Journal of Translational Medicine
Exciting breakthrough offers hope for Long COVID patients
Published May 7, 2024
Author Emma O'Connor - Griffith University
https://news.griffith.edu.au/2024/05/07/exciting-breakthrough-offers-hope-for-long-covid-patients/
Opioid Addiction Medication Could Bring Relief to Long COVID Patients
Naltrexone offers hope for alleviating various long COVID symptoms, including brain fog and muscle fatigue.
Published: May 9, 2024 Blake Forman
Technology Networks, Immunology & Microbiology
I’ve lost everything: Globetrotting DJ bedbound by long Covid says condition cost him career, friends and mobility
Staff Reporter10 May 2024
Addiction Medication Offers New Hope for Long COVID Patients
Featured in Neurology Neuroscience·May 7, 2024